SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study-Reference-Cited by-同舟云学术

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study

Published:2014-03-29 Issue:1 Volume:166 Page:98-108
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Nordström Lena¹,Sernbo Sandra¹,Eden Patrik²,Grønbæk Kirsten³,Kolstad Arne⁴,Räty Riikka⁵,Karjalainen Marja‐Liisa⁶,Geisler Christian³,Ralfkiær Elisabeth⁷,Sundström Christer⁸,Laurell Anna⁹,Delabie Jan¹⁰,Ehinger Mats¹¹,Jerkeman Mats¹²,Ek Sara¹

Affiliation:

1. Department of Immunotechnology CREATE Health Lund UniversityLund Sweden

2. Department of Astronomy and Theoretical Physics Lund University Lund Sweden

3. Department of Haematology Rigshospitalet Copenhagen Denmark

4. Department of Oncology The Norwegian Radium Hospital Oslo Norway

5. Departments of Haematology and Oncology Helsinki University Central HospitalHelsinki Finland

6. Department of Pathology HUCH Laboratory Diagnostics Helsinki University Central Hospital Helsinki Finland

7. Department of Pathology Rigshospitalet Copenhagen Denmark

8. Department of Immunology, Genetics and Pathology Uppsala UniversityUppsala Sweden

9. Department of Oncology Uppsala University Hospital Uppsala Sweden

10. Department of Pathology Division of Cancer Medicine and Surgery Oslo University Hospital Oslo Norway

11. Department of Pathology University Hospital Lund Lund Sweden

12. Department of Oncology University Hospital Lund Lund Sweden

Funder

BioCARE

Cancerfonden

Crafoord

Vetenskapsrï¿½det

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.12854

Reference34 articles.

1. A new look at the statistical model identification

2. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype

3. Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms

4. Knock-down of SOX11 induces autotaxin-dependent increase in proliferationin vitroand more aggressive tumorsin vivo

5. Regression models and life‐tables;Cox D.R.;Journal of the Royal Statistical Society Series B: Methodological,1972

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of mantle cell lymphoma (MCL) detected with initial symptoms in the oral region;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2024-08

2. Clinical and pathological characteristics of blastoid mantle cell lymphoma: a single institution experience;F1000Research;2024-07-26

3. Clinical and pathological characteristics of blastoid mantle cell lymphoma: a single institution experience;F1000Research;2024-05-22

4. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma;Blood;2024-05-09

5. Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine–rituximab;British Journal of Haematology;2023-10-25